Enhanced Dissolution Rate of Trimethoprim by Co-grinding Technique with Polyvinylpyrrolidone K-30 Polymer

  • AUZAL HALIM UNIVERSITAS ANDALAS
  • SYUKRAN HAMDENI UNIVERSITAS ANDALAS
  • ERIZAL ZAINI UNIVERSITAS ANDALAS

Abstract

Improvement of the dissolution rate of trimethoprim (TMP) as a model for a poorly water-soluble drug by solid state co-grinding technique with hydrophilic polymer polyvinylpyrrolidone K-30 (PVP K-30) using ball milling apparatus have been investigated. The ratios of drug to hydrophilic polymer were 1:1, 1:3 and 1:5. The solid state interaction of co-ground and physical mixture were characterized by powder X-ray diffraction, thermal DTA, SEM and FT-IR spectroscopy analysis. The dissolution studies were carried out in USP type I apparatus. The result of powder X-ray diffraction analysis showed that the co-grinding of TMP with PVP K-30 decreased the drug’s crystalinity. The endothermic peak of TMP of co-ground products shifted to lower temperature and peak intensity decreased significantly. Powder X-ray diffraction and DTA analysis indicated transformation of crystalline state of TMP to amorphous form by co-grinding with PVP K-30. FT-IR Spectra indicated that no chemical interaction between TMP and PVP K-30 in the co-grounds. Significant enhancement in dissolution rates were observed with the co-ground products of TMP and PVP K-30 as compared to the intact TMP and its physical mixture. In general, the dissolution rates of TMP in the co-grounds were enhanced as the polymer ratio increased.

References

1. Racz I. Drug formulation. New York: John Wiley and Sons; 1989. 323-6.
2. Shargel L, Yu A. Applied Biopharmaceutics and pharmacokinetics. 3rd edition. Norwalk Connecticut: Appleton & Lange; 1993. 136-8.
3. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000.50:47-60.
4. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion system. J Pharm Sci. 1971.60(9):1281-302.
5. Abdou HM. Dissolution, bioavaibility and bioequivalence. Easton Pennsylvania: Mack Publishing Company; 1989. 11.
6. Sugimoto M, Okayagi T, Narisawa S, Koida Y, Nakajima K. Improvement of dissolution characteristics and bioavailability of poorly water soluble drugs by novel co-grinding method using water soluble polymer. Int J Pharm 1998. 160: 11-9.
7. Friedrich H, Nada A, Bodmeir R. Solid state and dissolution rate characterization of co-ground mixture of nifedipine and hydrophilic carriers. Drug Dev Ind Pharm. 2005.31:719-28.
8. Garg A, Singh S. Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate. Drug Dev Ind Pharm. 2009.35:455-70.
9. Li N, Zhang Y-H, Wu Y-N, Xiong X-L, Zhang YH. Inclusion complex of trimethoprim with β-cyclodextrin. J Pharm and Bio Anal. 2005.39:824-9.
10. Zaini E, Halim A, Soewandhi SN, Setyawan D. Peningkatan laju pelarutan trimetoprim melalui metode kokristalisasi dengan nikotinamida. Jurnal Farmasi Indonesia. 2011.5(4):205-12.
11. Chono S, Takeda E, Seki T, Morimoto K. Enhancement of the dissolution rate and gastrointestinal absorption of pranlukast as a model of poorly water soluble drug by grinding with gelatin. Int J Pharm. 2008.347:71-8.
12. Mura P, Faucci MT, Maestrelli S, Furlanetto, Pinzauti S. Characterization of physicochemical properties of naproxen systems with amorphous-cyclodextrin-epichlorohydrin polymers. J Pharm and Bio Anal. 2002.29:1015-24.
Published
2013-04-30
How to Cite
HALIM, AUZAL; HAMDENI, SYUKRAN; ZAINI, ERIZAL. Enhanced Dissolution Rate of Trimethoprim by Co-grinding Technique with Polyvinylpyrrolidone K-30 Polymer. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 11, n. 1, p. 1-6, apr. 2013. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/224>. Date accessed: 19 dec. 2024.
Citation Formats
Issue
Vol 11 No 1 (2013): JIFI
Section
Articles
License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.